These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 723791)

  • 1. A contribution of cellular immunity to protection against influenza in man.
    Jennings R; Fenton RJ; McEntegart MG; Potter CW
    Med Microbiol Immunol; 1978 Nov; 166(1-4):51-62. PubMed ID: 723791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to attenuated influenza virus WRL 105 infection induced by heterologous, inactivated influenza A virus vaccines.
    Potter CW; Jennings R; Nicholson K; Tyrrell DA; Dickinson KG
    J Hyg (Lond); 1977 Dec; 79(3):321-32. PubMed ID: 270523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):361-70. PubMed ID: 6863910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.
    Clark A; Potter CW; Jennings R; Nicholl JP; Langrick AF; Schild GC; Wood JM; Tyrrell DA
    J Hyg (Lond); 1983 Jun; 90(3):351-9. PubMed ID: 6863909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis.
    Al-Khayatt R; Jennings R; Potter CW
    J Hyg (Lond); 1984 Oct; 93(2):301-12. PubMed ID: 6389697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
    Schmidt S; Süss J; Oehring H; Schmidt J
    Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.
    Masurel N; Laufer J
    J Hyg (Lond); 1984 Jun; 92(3):263-76. PubMed ID: 6736638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
    Cate TR; Couch RB
    Infect Immun; 1982 Oct; 38(1):141-6. PubMed ID: 7141686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A graded-dose study of inactivated, surface antigen influenza B vaccine in volunteers: reactogenicity, antibody response and protection to challenge virus infection.
    Goodeve A; Potter CW; Clark A; Jennings R; Schild GC; Yetts R
    J Hyg (Lond); 1983 Feb; 90(1):107-15. PubMed ID: 6822725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge.
    Fries LF; Dillon SB; Hildreth JE; Karron RA; Funkhouser AW; Friedman CJ; Jones CS; Culleton VG; Clements ML
    J Infect Dis; 1993 Mar; 167(3):593-601. PubMed ID: 8440931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reaction but no avidity change of the serum antibody response after influenza vaccination.
    Brokstad KA; Cox RJ; Major D; Wood JM; Haaheim LR
    Vaccine; 1995 Nov; 13(16):1522-8. PubMed ID: 8578836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses.
    Gorse GJ; Belshe RB
    Scand J Infect Dis; 1991; 23(1):7-17. PubMed ID: 2028230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody and cytotoxic T lymphocyte responses of humans to live and inactivated influenza vaccines.
    Ennis FA; Yi-Hua Q; Schild GC
    J Gen Virol; 1982 Feb; 58(Pt 2):273-81. PubMed ID: 7038041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of resistance to influenza virus infection in animal models.
    Potter CW; McLaren C; Jennings R
    Dev Biol Stand; 1975; 28():307-18. PubMed ID: 1126574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential infection or immunization of ferrets with a series of influenza A (H3N2) strains (report to the Medical Research Council's Sub-Committee on influenza Vaccines (CDVIP/IV)).
    Potter CW; Jennings R; Ali MJ; Wood JM; Dunleavy U; Tyrrell DA
    Epidemiol Infect; 1987 Oct; 99(2):501-15. PubMed ID: 3315713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection.
    Oxford JS; Schild GC; Potter CW; Jennings R
    J Hyg (Lond); 1979 Feb; 82(1):51-61. PubMed ID: 105040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2).
    Larson HE; Tyrrell DA; Bowker CH; Potter CW; Schild GC
    J Hyg (Lond); 1978 Apr; 80(2):243-8. PubMed ID: 632564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity to influenza virus infection induced by heterologous, inactivated vaccines.
    Potter CW; Jennings R; Nicholson K
    Med Microbiol Immunol; 1978 Nov; 166(1-4):99-108. PubMed ID: 723794
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell-mediated cytotoxicity following influenza infection and vaccination in humans.
    Reichman RC; Pons VG; Murphy BR; Caplan EA; Dolin R
    J Med Virol; 1979; 4(1):1-14. PubMed ID: 231094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.